Workshops & Webinars 2024
Our exciting initiative continues!
Our Experts to Experts Program aims to intensify the dialogue between you and our experts through on-site workshops and webinars. This program offers a continuous exchange of knowledge for the entire Zytomed Systems product portfolio. Explore your options.
You can request the program including a series of scientific activities for the upcoming months at workshop@zytomed-systems.de or webinar@zytomed-systems.de.
If you need further information or have any questions, please do not hesitate to contact us.
In May 2024 the S3 guideline "Prostate Cancer" (version 7.0) was updated. For the first time it is recommended to sequence genes involved in homologous recombination repair (HRR), e. g. ATM, BRCA1/2, BRIP1, CDK12, CHEK2, FANCA, HDAC2 and PALB2, before initiating a systemic therapy for castration-resistant prostate cancer (mCRPC).
Recently, a second ZytoDot ® 2C probe for detecting rearrangements of the NTRK genes has become available: the new ZytoDot ® 2C SPEC NTRK3 Break Apart Probe (C-3079-100). Together with the already existing ZytoDot ® 2C SPEC NTRK1 Break Apart Probe (C-3078-100), a large range of NTRK rearrangements can be covered now. Both probes are designed for the qualitative detection of NTRK3 and NTRK1 rearrangements in FFPE tissue using the ZytoDot ® 2C CISH implementation Kit.